Fundamentals of diagnosis and therapy of glaucoma according to the fourth edition of guidelines of the European Society of Ophthalmology
Article Sidebar
Main Article Content
Abstract
The guidelines of the European Glaucoma Society (EGS) define standards for diagnosis and management of glaucoma. The following article summarises the main findings contained in the fourth edition of EGS 2014. A monotherapy is suggested as the first-line treatment, and in case of the absence of its effectiveness changing the drug to another one or adding a second preparation is recommended. For the efficacy and safety of treatment, the preferred drugs are complex ones, constituting a combination of two active substances in one formulation. The need for more frequent condition monitoring of a patient whose treatment is carried out with generic drugs is important. The treatment of glaucoma must also take into consideration modern laser and surgical methods
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright: © Medical Education sp. z o.o. License allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Address reprint requests to: Medical Education, Marcin Kuźma (marcin.kuzma@mededu.pl)
References
2. The AGIS Investigators. The Advanced glaucoma intervention study (AGIS): The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol. 2000; 130: 429-40.
3. Hodapp E, Parrish RK, Anderson DR. Clinical decisions in glaucoma. CV Mosby Company, St Louis 1993.
4. Mills RP, Budenz DL, Lee PP et al. Categorising the stage of glaucoma from pre-diagnosis to end-stage disease. Am J Ophthalmol. 2006; 141: 24-30.
5. Katsimpris JM, Theoulakis PE, Papadopoulos GE et al. Ocular pulse amplitude measurement using Pascal dynamic contour tonometer in glaucoma patients. Klin Monbl Augenheilkd. 2014; 23: 363-7.
6. Heijl A, Leske MC, Bengtsson B. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002; 120(10): 1268-79.
7. Van der Valk R, Webers CA, Schouten JS. Intraocular pressure-lowering effects of all commonly used glaucoma drugs: a metaanalysis of randomized clinical trials. Ophthalmology. 2005; 112(7): 1177-85.
8. Khouri AS, Realini T, Fechtner RD. Use of fixed-dose combination drugs for the treatment of glaucoma. Drugs Aging. 2007; 24(12): 1007-16.
9. Denis P, Andrew R, Wells D. A comparison of morning and evening installation of a combination travoprost 0,004%/timolol 0,5% ophthalmic solution. Eur J Ophthalmol. 2005; 3: 407-15.
10. Aung T, Laganowska G, Hernandez-Paredes T et al. Twice-daily brinzolamide /brimonidine fixed-combination versus brinzolamide or brimonidine in open-angle glaucoma or ocular hypertension. Ophthalmology. 2014, Jul 23: 1-8 [Epub ahead of print].
11. Erb C, Lanzl I, Seidova S-F et al. Preservative-free tafluprost 0,0015% in the treatment of patients with glaucoma and ocular hypertension. Adv Ther. 2011; 28(7): 575-85.
12. Gandolfi S, Predes T, Goldberg I et al. Travoprost BAK-free Clinical Study Group: comparison of a travoprost BAK-free formulation preserved with polyquaternium-1 with BAK-preserved travoprost in ocular hypertension or open angle glaucoma. Eur J Ophthalmol. 2012; 22(1): 34-44.
13. Katz G, Springs CL, Craven ER et al. Ocular surface disease in patients with glaucoma or ocular hypertension treated with either BAK–preserved latanoprost or BAK-free travoprost. Clinical Ophthalmology. 2010; 4: 1253-61.
14. Ho J-D., Hu C-C, Lin H-C. Antiglaucoma medications during pregnancy and the risk of low birth weight: a population-based study. Br J Ophthalmol. 2009; 93: 1283-6.
15. [No authors listed] The Glaucoma Laser Trial (GLT) and glaucoma laser trial follow-up study: 7 Results. Am J Ophthalmol. 1995; 120(6): 718-31.
16. Katz LJ, Steinmann WC, Kabir A. Selective laser trabeculoplasty versus medical therapy as initial treatment of glaucoma: a prospective, randomized trial. J Glaucoma. 2012; 21(7): 460-8.
17. Denis P, Lafuma A, Berdeaux G. Medical outcomes of glaucoma therapy from a nationwide representative survey. Clin Drug Invest. 2004; 24(6): 343-52.